Home » Topics » BioWorld Science

BioWorld Science
RSS

Blade Therapeutics initiates phase I study of BLD-2660

July 18, 2018

First cohort dosed in phase I study of OMS-527

July 18, 2018

Discovery of novel PET tracer for imaging CSF-1R in the brain

July 18, 2018

Novel CD-1db/db mouse model of type 2 diabetes with progressive kidney fibrosis

July 18, 2018

ONO-8590580, a GABA(A)-alpha5 negative allosteric modulator enhancing hippocampal memory function

July 18, 2018

Hearing light, no synesthesia required

July 18, 2018

Hot flashes are hypothalamic

July 18, 2018

BAFF and Beffs

July 18, 2018

Good-enough HCV vaccine could reduce transmission

July 18, 2018

CRISPR reprograms T cells

July 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...